Oak Ridge Investments’s Corcept Therapeutics CORT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1M	Buy	24,870 +257	+1%	+$9.61K	0.07%	125
2025 Q4	$857K	Sell	24,613 -887	-3%	-$69.7K	0.05%	131
2025 Q3	$2.12M	Buy	25,500 +2,177	+9%	+$158K	0.14%	89
2025 Q2	$1.71M	Buy	23,323 +2,784	+14%	+$202K	0.12%	96
2025 Q1	$2.35M	Sell	20,539 -8,452	-29%	-$514K	0.2%	78
2024 Q4	$1.46M	Sell	28,991 -89	-0.3%	-$4.66K	0.11%	103
2024 Q3	$1.35M	Sell	29,080 -1,192	-4%	-$42.4K	0.12%	99
2024 Q2	$984K	Buy	+30,272	New	+$829K	0.09%	112
2019 Q1	–	Sell	-381,567	Closed	-$5.1M	–	170
2018 Q4	$5.1M	Sell	381,567 -142,243	-27%	-$1.88M	0.37%	97
2018 Q3	$7.34M	Sell	523,810 -65,570	-11%	-$916K	0.41%	92
2018 Q2	$9.27M	Buy	589,380 +148,212	+34%	+$2.58M	0.53%	85
2018 Q1	$7.26M	Sell	441,168 -119,886	-21%	-$2.22M	0.4%	89
2017 Q4	$10.1M	Buy	+561,054	New	+$10.2M	0.48%	80